CQU-33002-96216
3 vaccinations
7 coded responses
34 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 921 / CA
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-20
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-04-05
-
2021-04-10
Dose 2 — Pfizer-BioNTech
- 2021-04-10
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-24
- 2021-05-01
-
2021-05-08
Survey response — day 28, dose 2MedDRA: Nasopharyngitis — Feeling: FairFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-15
- 2021-05-22
-
2021-07-10
Survey response — 3 months, dose 2MedDRA: Diarrhoea — Feeling: GoodFree text: Consistent diarrheaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-09
Survey response — 6 months, dose 2MedDRA: Cough, Headache, Pyrexia, SARS-CoV-2 test negative — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough that lasted for over a month, tested negative for COVID, strep, and bronchitis. Fever and headache for only one day out of the month.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-14
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-14
- 2021-10-15
- 2021-10-17
- 2021-10-19
- 2021-10-23
- 2021-10-28
- 2021-11-04
- 2021-11-13
-
2021-11-18
Survey response — day 35, dose 3MedDRA: Exposure to SARS-CoV-2, Headache, Respiratory tract congestion, Rhinorrhoea, Upper-airway cough syndrome — Feeling: Fair · Be unable to work or attend schoolFree text: Congestion, runny nose, post nasal drip, headache, contact with a covid-positive individualMedDRA releases: 2024-11 · check-in free text available
-
2021-11-25
Survey response — day 42, dose 3MedDRA: Fatigue, Headache, Pain, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend schoolFree text: Headache, body ache, fatigue, congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-04-16
Survey response — 6 months, dose 3MedDRA: Cough, Headache, Oropharyngeal pain, Productive cough — Feeling: FairFree text: Sore throat, cough, phlegm, headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Survey response — 12 months, dose 3MedDRA: Fatigue, Nausea, Productive cough, Rhinorrhoea, Sinus congestion, Sneezing — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Body fatigue, sneezing, sinus congestion, runny nose, phlegm, nauseaMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-20 | Pfizer-BioNTech | |
| 2 | 2021-04-10 | Pfizer-BioNTech | |
| 3 | 2021-10-14 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 28, dose 2
Symptoms: Cold symptoms
Release 9 — 3 months, dose 2
Symptoms: Consistent diarrhea
Release 10 — 6 months, dose 2
Symptoms: Cough that lasted for over a month, tested negative for COVID, strep, and bronchitis. Fever and headache for only one day out of the month.
Release 10 — day 35, dose 3
Symptoms: Congestion, runny nose, post nasal drip, headache, contact with a covid-positive individual
Release 10 — day 42, dose 3
Symptoms: Headache, body ache, fatigue, congestion, runny nose
Release 11 — 6 months, dose 3
Symptoms: Sore throat, cough, phlegm, headache
Release 12 — 12 months, dose 3
Symptoms: Body fatigue, sneezing, sinus congestion, runny nose, phlegm, nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release